HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip J Gold Selected Research

cabozantinib

10/2022A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip J Gold Research Topics

Disease

9Neoplasms (Cancer)
11/2023 - 10/2009
4Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 09/2006
4Adenocarcinoma
01/2023 - 09/2010
2Colonic Neoplasms (Colon Cancer)
10/2022 - 01/2019
2Cholangiocarcinoma
08/2012 - 12/2011
2Esophageal Neoplasms (Esophageal Cancer)
05/2012 - 09/2010
1Breast Neoplasms (Breast Cancer)
02/2024
1Microsatellite Instability
10/2022
1Peripheral Nervous System Diseases (PNS Diseases)
10/2022
1Turcot syndrome
10/2022
1Hepatocellular Carcinoma (Hepatoma)
02/2013
1Venous Thromboembolism
08/2012
1Carcinoma (Carcinomatosis)
08/2012
1Diarrhea
02/2012
1Anorexia
02/2012
1Exanthema (Rash)
02/2012
1Fatigue
02/2012
1Nausea
02/2012
1Vomiting
02/2012
1Gallbladder Neoplasms (Gallbladder Cancer)
12/2011
1Pathologic Complete Response
12/2011
1Heart Diseases (Heart Disease)
10/2009

Drug/Important Bio-Agent (IBA)

3pembrolizumabIBA
11/2023 - 01/2020
3Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 12/2011
3Capecitabine (Xeloda)FDA Link
10/2022 - 09/2006
2Trastuzumab (Herceptin)FDA Link
01/2023 - 01/2020
2margetuximabIBA
01/2023 - 01/2020
2Tyrosine Kinase InhibitorsIBA
10/2022 - 02/2012
2Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 12/2011
2Irinotecan (Camptosar)FDA LinkGeneric
05/2012 - 09/2006
2Cetuximab (Erbitux)FDA Link
05/2012 - 09/2010
1Sunitinib (Sutent)FDA Link
02/2024
1NivolumabIBA
09/2023
1IpilimumabIBA
09/2023
1Circulating Tumor DNAIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1regorafenibIBA
10/2022
1cabozantinibIBA
10/2022
1Leucovorin (Folinic Acid)FDA Link
10/2022
1Monoclonal AntibodiesIBA
01/2020
1codrituzumabIBA
02/2013
1GlypicansIBA
02/2013
1Alkaline PhosphataseIBA
08/2012
1BilirubinIBA
08/2012
1Sorafenib (BAY 43-9006)FDA Link
08/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012
1Cisplatin (Platino)FDA LinkGeneric
05/2012
1Adenosine Triphosphate (ATP)IBA
02/2012
1Phosphotransferases (Kinase)IBA
02/2012
1bosutinibIBA
02/2012
1GemcitabineFDA Link
12/2011
1Messenger RNA (mRNA)IBA
12/2011
1ErbB Receptors (EGF Receptor)IBA
09/2010
1romidepsin (FK228)FDA Link
10/2009
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
09/2006
1Thymidylate SynthaseIBA
09/2006
1Thymidine PhosphorylaseIBA
09/2006

Therapy/Procedure

7Therapeutics
01/2023 - 09/2006
4Drug Therapy (Chemotherapy)
10/2022 - 10/2009
2Adjuvant Chemotherapy
10/2022 - 01/2019
2Radiotherapy
05/2012 - 12/2011
1Duration of Therapy
01/2019
1Neoadjuvant Therapy
12/2011